Bristol-Myers Squibb Company to Present Data on 13 Oncology Compounds During 2010 American Society of Clinical Oncology Annual Meeting

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY), a global leader in oncology drug development, today announced that more than 95 scientific abstracts on 13 of its oncology compounds will be featured at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from June 4-8.

MORE ON THIS TOPIC